MedPath

Homoeopathic Medicine for Fatty Liver

Phase 2
Conditions
Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified
Registration Number
CTRI/2023/08/056609
Lead Sponsor
The Calcutta Homoeopathic Medical College and Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Cases attending OPD with ultra-sonographic evidence of grade-1 fatty liver.

2. Literate patients; ability to read and write in Bengali, Hindi, and/or English.

3. Patients giving written informed consent

Exclusion Criteria

1.Cases too sick for consultation.

2. Patient unwilling to take part or not giving consent to join the study.

3. Diagnosed cases of viral hepatitis, Wilson disease, hemochromatosis,

celiac disease, liver cirrhosis, hepatocellular carcinoma or any other

malignancies or any uncontrolled systemic diseases, unstable mental or

psychiatric illness or other uncontrolled or life-threatening illness

affecting quality of life or any organ failure.

4. Cases with history of usage of some drugs (e.g., amiodarone,

corticosteroids, methotrexate, tamoxifen, synthetic estrogens, valproic

acid, intravenous tetracycline, and highly active antiretroviral drugs)

5. Self-reported immune compromised state.

6. Alcohol or any other substance abuse and/or dependence.

7. Pregnant and lactating women.

8. Patient simultaneously taking part in other clinical trial in the same

institute.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ltrasonographyTimepoint: at baseline & after 6 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
EQ-5D-5L QuestionnaireTimepoint: at baseline, after 3 months & after 6 months;Lipid profileTimepoint: at baseline, after 3 months & after 6 months;Liver function testTimepoint: at baseline, after 3 months & after 6 months
© Copyright 2025. All Rights Reserved by MedPath